ICURE PHARMACEUTICAL INC.
🇵ðŸ‡Philippines
- Country
- 🇵ðŸ‡Philippines
- Ownership
- Public
- Established
- 2000-05-29
- Employees
- 280
- Market Cap
- -
- Website
- http://www.icure.co.kr
A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease
- First Posted Date
- 2017-06-23
- Last Posted Date
- 2021-02-11
- Lead Sponsor
- Icure Pharmaceutical Inc.
- Target Recruit Count
- 399
- Registration Number
- NCT03197740
- Locations
- 🇰🇷
46 Sites including Konkuk University Medical Center, Seoul, Korea, Republic of
A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects.
- First Posted Date
- 2014-06-30
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- Icure Pharmaceutical Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT02178124
- Locations
- 🇰🇷
ASAN Medical Center, Seoul, Korea, Republic of
A Phase I Clinical, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects
- First Posted Date
- 2013-05-23
- Last Posted Date
- 2014-06-30
- Lead Sponsor
- Icure Pharmaceutical Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT01860625
- Locations
- 🇰🇷
ASAN Medical Center, Seoul, Korea, Republic of
© Copyright 2024. All Rights Reserved by MedPath